GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Streamex Corp
Shares of BioSig Technologies, a company developing cardiology systems, reflect its struggle for commercialization. Their price trajectory is volatile and depends on sales news for its PURE EP system and the need for additional funding.
Share prices of companies in the market segment - Holding
Streamex, affiliated with BioSig Technologies, develops advanced medical devices, specifically systems for minimizing noise in biosignal acquisition. We've classified it as a "Holding," and the chart below shows how investors value companies at the intersection of medicine and high technology.
Broad Market Index - GURU.Markets
BioSig Technologies develops advanced medical devices, specifically systems for minimizing noise in biosignal acquisition. It is a component of the GURU.Markets index. The chart below represents the market. See how this company's stock compares to the medical technology sector.
Change in the price of a company, segment, and market as a whole per day
STEX - Daily change in the company's share price Streamex Corp
For BioSig, a medical technology company, change_co is a measure of innovation volatility. Daily fluctuations reflect news about the clinical application of its cardiology technology. This metric forms the basis for analyzing medical technology companies on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Holding
The holding company sector in which Streamex Corp operates is highly dynamic. This chart reflects the average daily volatility of the industry. It serves as a benchmark for assessing how sensitive Streamex's business is to overall trends and the performance of its subsidiaries.
Daily change in the price of a broad market stock, index - GURU.Markets
Biosig (Streamex's parent company) has developed a cutting-edge system for obtaining clear cardiac signals. The cardiology medical equipment market is highly technological. The chart below shows the volatility in this sector, allowing one to assess how the market is accepting the parent company's innovations.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Streamex Corp
Streamex Corp., which operates under the BioSig brand, has been trending for the past year, reflecting the commercialization of its arrhythmia treatment navigation system. Its 12-month market cap reflects the success of installing its PURE EP platform in cardiac centers, a fundamental step in validating the clinical and economic value of its technology.
Annual dynamics of market capitalization of the market segment - Holding
Biosig Technologies, through its subsidiary, is developing a cutting-edge cardiac imaging system. The success of such medical companies depends on clinical acceptance and commercialization. Its dynamics will be highly volatile, reflecting the speculative nature of this segment.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
The STEX ticker belongs to the ETF, not Streamex. The website is owned by BioSig (BSGM). BioSig, with its cardiology technology, is a speculative medical story. Its stock price isn't tied to the economy, but rather to its success in commercialization and regulatory approvals.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Streamex Corp
Streamex's capitalization, as a holding company, will reflect the value of its assets. Monthly fluctuations on the chart will represent the combined performance of its subsidiaries and the assessment of its investments in various sectors of the economy.
Monthly dynamics of market capitalization of the market segment - Holding
Streamex Corp, through its subsidiaries, develops medical technologies. The medical device sector is driven by innovation and demographic trends, such as an aging population. The chart below shows how investors assessed the prospects of companies developing new diagnostic and therapeutic devices.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Biosig Technologies (ticker symbol STEX) is a medical device company developing technology to improve cardiac signal quality. Its stock price is driven not by the market, but by progress in commercializing its product and its acceptance in the medical community. It's a bet on technological superiority in a niche market.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Streamex Corp
The weekly performance of Streamex Corp, a holding company, reflects the performance of its subsidiaries. Its stock price is sensitive to news and the financial performance of its holdings, which can operate in various industries. The chart below shows how short-term events within this diversified portfolio affect the company's overall valuation.
Weekly dynamics of market capitalization of the market segment - Holding
Is Streamex Corp moving in line with its sector? The chart below compares the company's weekly share price performance with the industry average. This allows us to assess how its diversified portfolio responds to overall market trends compared to more focused companies.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Streamex Corp is a holding company with diversified interests. This chart compares its weekly performance to the broader market to assess whether its structure helps smooth out volatility or, conversely, whether successes or failures in one segment cause sharp movements.
Market capitalization of the company, segment and market as a whole
STEX - Market capitalization of the company Streamex Corp
The valuation of Streamex Corp (formerly BioSig Technologies) on the chart tells the story of a company struggling to find its niche. Initially focused on medical devices, its market cap now reflects the uncertainty and speculative interest in its new, as yet unclear, direction. The dynamics highlight all the risks of such a transformation.
STEX - Share of the company's market capitalization Streamex Corp within the market segment - Holding
Streamex Corp (formerly BioSig Technologies) is a holding company whose market share and market capitalization reflect the value of its portfolio of assets, including technologies in the medical and other sectors.
Market capitalization of the market segment - Holding
The chart below reflects the total market capitalization of diversified holdings. Streamex (formerly BioSig Technologies) is an example of a company changing its strategy. The dynamics in the chart show how the market is assessing this transformation and the potential of its new business lines.
Market capitalization of all companies included in a broad market index - GURU.Markets
This chart shows the market valuation of a medical technology company. Streamex Corp's market capitalization (linked to BioSig) reflects investors' faith in its innovation. The line illustrates how a small healthcare company is fighting for its share in a highly competitive global industry.
Book value capitalization of the company, segment and market as a whole
STEX - Book value capitalization of the company Streamex Corp
This chart reflects the tangible and intangible assets of Streamex Corp. The company's foundation is its portfolio of patents and developments in biometric technologies, particularly heart rate analysis. The dynamics show how the company manages its main asset—its intellectual property.
STEX - Share of the company's book capitalization Streamex Corp within the market segment - Holding
This holding's tangible assets are its subsidiaries, including one that develops medical technologies. The chart reflects its share of physical assets, which represent R&D centers and equipment that form the basis for its innovations in biosignaling.
Market segment balance sheet capitalization - Holding
Below you can see the overall book value of the medical equipment sector. Compared to this, Streamex (Biosig), with its biosignaling technology, looks "light." Its value lies in its unique technology and patents, not in mass production, which contrasts with consumables manufacturers.
Book value of all companies included in the broad market index - GURU.Markets
Streamex Corp, judging by its ticker symbol, may be linked to Biosig, a holding company that develops bioelectronic medicine technologies. The company's assets are not hospitals, but patents and prototypes of complex medical devices that could change the reality of surgery.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Streamex Corp
Streamex (Biosig)'s balance sheet is its cash and patents. Its market capitalization is a bet on its biosignal processing technology becoming in-demand in medicine. The MvsBCap_Co chart shows how much the "dream" of a new medical standard is worth compared to the company's actual assets.
Market to book capitalization ratio in a market segment - Holding
Streamex Corp is a holding company with assets across various sectors. This chart shows how the market values its diversified portfolio of businesses. The valuation is the sum of its parts and reflects investors' confidence in management's ability to effectively manage these assets.
Market to book capitalization ratio for the market as a whole
Streamex Corp, judging by its ticker symbol STEX and the associated website biosig.com, may be related to BioSig Technologies, a company developing electrophysiology technologies. This demonstrates that data can sometimes be inaccurate, and it's important to look at the underlying business—in this case, medical technology, where intellectual property is a key asset.
Debts of the company, segment and market as a whole
STEX - Company debts Streamex Corp
STEX is a ticker symbol historically associated with BioSig Technologies. As a medical device company, it uses debt to fund R&D and commercialization. This chart would show the company raising capital to bring its cardiology system to market, which requires significant investment before generating stable revenue.
Market segment debts - Holding
Streamex Corp., based on its ticker symbol and information, may be linked to BioSig Technologies, a company developing bioelectronic medicine technologies. Bringing new medical equipment to market is a lengthy and expensive process. This chart may reflect how the company funds its research and development in this complex and regulated field.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Streamex Corp
Biosig Technologies, listed as Streamex, develops cardiology systems. This chart shows the extent to which the company uses debt to fund R&D and commercialization. For a manufacturer of complex medical equipment, high debt is a risk associated with a long sales cycle and the need to convince a conservative medical community of the benefits of new technology.
Market segment debt to market segment book capitalization - Holding
Streamex Corp., an affiliate of BioSig, is likely a holding company or technology company in the medical device industry. Developing medical technology requires significant investment. The chart shows how the debt structure of this small company compares to the overall market capitalization of the entire medical device sector.
Debt to book value of all companies in the market
BioSig Technologies (STEX) is a developer of an advanced biosignal processing system that improves data clarity for cardiologists. This chart reflects the overall level of debt in the economy, serving as an indicator of capital availability. For an innovative medtech company at the commercialization stage, it is important to understand these trends to choose the optimal path to finance its growth.
P/E of the company, segment and market as a whole
P/E - Streamex Corp
For Streamex Corp, a holding company, this chart will reflect the combined valuation of its various assets. The P/E will depend on the industries its subsidiaries operate in. The holding company's valuation often trades at a discount to the sum of its component values, which may explain the moderate value of the ratio.
P/E of the market segment - Holding
This chart shows the average P/E valuation for holding companies. For Streamex, given its diversified portfolio, this is an important benchmark. It helps understand whether it trades at a discount to the total value of its assets, which is typical for holding companies, and how the market generally values such entities.
P/E of the market as a whole
Streamex Corp, associated with BioSig Technologies, is likely a holding company or technology company, possibly in the medical field. Such entities are often created to own patents or develop new technologies. Their valuation may be speculative and dependent on development news, which is interesting to compare with the overall market backdrop on this chart.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Streamex Corp
Streamex Corp. is likely a holding company, possibly related to BioSig Technologies, as indicated in the data. This chart would reflect expectations for its core operating business. If it is BioSig, the valuation would depend on the success of its cardiology imaging system, making it a speculative medical technology investment.
Future (projected) P/E of the market segment - Holding
Streamex Corp is a holding company with various assets. This chart compares the company's future profitability expectations with sector forecasts. It reflects how the market assesses management's ability to effectively manage a diversified portfolio of businesses and create long-term shareholder value.
Future (projected) P/E of the market as a whole
Streamex Corp is a holding company whose assets and operating performance are subject to change, reflecting strategic acquisitions and investments in various sectors. This chart of general market expectations serves as a barometer for investors to assess the company's management's ability to effectively allocate capital and create value.
Profit of the company, segment and market as a whole
Company profit Streamex Corp
Streamex Corp, formerly known as BioSig Technologies, is a holding company focused on the development and commercialization of technologies. Its primary asset was related to cardiology medical equipment. Its financial results reflect its strategy for managing and monetizing its technology assets.
Profit of companies in the market segment - Holding
Streamex Corp (via Biosig) is developing innovative technology for obtaining clearer ECG signals, which is important for cardiology. The company is on track for widespread adoption. This chart for the medical device sector illustrates how breakthrough technologies can improve diagnostics and impact the future profitability of the entire industry by increasing accuracy and efficiency.
Overall market profit
Streamex Corp is a holding company whose activities can span multiple sectors. For such diversified entities, the overall economic situation, reflected in this chart, is a key factor. During periods of growth, most of its assets are likely to perform well, while during periods of decline, they will struggle.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Streamex Corp
Streamex Corp. is likely a holding company with assets in various sectors, possibly related to technology or media. The future profit projections shown in this chart represent the sum of expectations for its subsidiaries and depend on the success of the strategy for managing and developing these assets.
Future (predicted) profit of companies in the market segment - Holding
Streamex Corp is a holding company operating in various sectors. This chart shows the profit forecast for the entire holding sector. It reflects general expectations for the economic outlook, which impacts the company's diversified asset portfolio. This macroeconomic backdrop is key to assessing the holding's overall performance and strategy.
Future (predicted) profit of the market as a whole
Streamex Corp is a holding company with various assets. The holdings' performance reflects the health of the industries in which their subsidiaries operate. General economic forecasts, such as those shown in the chart, provide a general indicator of the health of the entire economy, which influences the holding's overall performance.
P/S of the company, segment and market as a whole
P/S - Streamex Corp
Streamex Corp is a holding company likely operating in streaming media or related technologies. Its revenue will depend on its ability to develop and monetize its platform or technology. This chart reflects investor expectations regarding the company's future potential in the rapidly growing but competitive streaming market.
P/S market segment - Holding
Streamex Corp is a holding company that invests in various businesses, often in biotechnology and medical devices. Its value and revenue depend on the success of its subsidiaries and investments. This chart shows the average valuation in the sector, allowing investors to compare Streamex's valuation with other diversified holdings.
P/S of the market as a whole
Streamex Corp is a hypothetical holding company that could combine assets in streaming video and digital media. Its success would depend on the quality of its content and its ability to monetize its audience. This chart would help assess how the market views the potential of such a player in the era of streaming wars, within the context of the overall economy.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Streamex Corp
Streamex Corp is a holding company. Its valuation depends on the future earnings of its subsidiaries. This chart reflects the combined investor expectations for all businesses within the holding.
Future (projected) P/S of the market segment - Holding
Streamex Corp is likely a holding company with interests in various sectors, possibly related to technology or media. This chart compares the company's estimated future earnings with other holdings. It shows how investors view its asset portfolio and management's value creation strategy.
Future (projected) P/S of the market as a whole
Streamex Corp, judging by its associated company, BioSig, may be a medical technology holding company. The success of such companies depends on innovation and its market acceptance. The general optimism evident in this chart influences hospital budgets and their willingness to invest in new technologies that can improve diagnostics and treatment.
Sales of the company, segment and market as a whole
Company sales Streamex Corp
Streamex Corp, formerly known as BioSig, is a holding company developing various technology projects. Its revenue depends on the success of its subsidiaries in commercializing their products, such as those in the field of biomedical signaling. The chart reflects early revenues from these technology initiatives.
Sales of companies in the market segment - Holding
Streamex Corp, formerly known as BioSig, is a holding company developing various technology projects. One of its key areas was the development of a system for cardiac procedures. The holding's structure allows it to invest in a variety of promising technologies. This chart illustrates how the holding's diversified approach allows it to operate in various, unrelated sectors.
Overall market sales
Streamex Corp, through its subsidiaries, develops medical technologies. Like many companies in this sector, its success depends on innovation and approvals. The economic situation, reflected in the chart, affects the availability of funding for R&D and the future solvency of the healthcare system.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Streamex Corp
Streamex Corp. is likely a shell or holding company associated with BioSig Technologies, which is developing technology to improve cardiac signal imaging during arrhythmia treatment procedures. This timeline would reflect analysts' expectations for the commercialization of BioSig's core technology.
Future (projected) sales of companies in the market segment - Holding
Streamex Corp is a holding company, likely with assets in technology or media, as suggested by its connection to Biosig. This chart shows general expectations for holding companies. It allows one to assess how management's strategy for managing and developing the asset portfolio impacts the company's overall value and prospects.
Future (projected) sales of the market as a whole
Streamex Corp, according to its associated website, biosig.com, may be involved in medical technology, possibly in the field of biosignals. This chart, reflecting healthcare costs, is important for such companies. Economic stability allows hospitals to invest in new diagnostic and monitoring technologies to improve patient care.
Marginality of the company, segment and market as a whole
Company marginality Streamex Corp
Streamex Corp is a holding company with diversified interests across various industries. Its primary objective is to efficiently allocate capital among its subsidiaries to maximize overall returns. This chart demonstrates how successfully the holding's management manages its asset portfolio to generate total returns.
Market segment marginality - Holding
Streamex Corp, affiliated with BioSig, likely operates in the medical technology sector. In this sector, profitability depends on the uniqueness of the technology, patent protection, and the ability to sell its solutions to hospitals and physicians. This chart reflects the balance between R&D and commercialization costs and the potential profitability of innovative products.
Market marginality as a whole
Streamex Corp (BioSig) is a company developing a cutting-edge signal processing system for cardiology that assists physicians during arrhythmia treatments. The overall profitability picture is irrelevant for them. Their future depends on the adoption of their technology by hospitals and surgeons. They are betting that their system will improve the outcomes of complex medical procedures.
Employees in the company, segment and market as a whole
Number of employees in the company Streamex Corp
Streamex Corp appears to be a holding or shell company. This chart likely shows a minimal team or no team at all. This is typical for companies that don't conduct any operational activities but serve, for example, as a target for mergers and acquisitions.
Share of the company's employees Streamex Corp within the market segment - Holding
Streamex Corp., associated with BioSig, is likely part of a holding company operating in the medical technology sector. This graph would show its stake in that industry. It would reflect a team of engineers and clinicians working on developing innovative devices, for example, to improve the diagnosis and treatment of cardiac arrhythmias.
Number of employees in the market segment - Holding
Streamex Corp is a holding company with interests in various sectors, including biotechnology. This chart reflects employment in the respective sector where its core asset operates. Headcount dynamics in a subsidiary are a key indicator of its operational activity and progress toward achieving its goals, which impacts the holding's value.
Number of employees in the market as a whole
Streamex Corp., judging by its ticker symbol and data, may be related to BioSig Technologies, which develops cardiology systems. If so, it would be a high-tech medical device company. This chart shows the overall labor market, where the medical device sector is one of the most innovative, creating jobs for engineers, scientists, and clinical trial specialists.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Streamex Corp (STEX)
Streamex Corp appears to be a holding company with an unclear focus. For such structures, the capitalization per employee ratio can be very high. A small team at the head office manages the subsidiaries, and the market values the entire holding company, not just the administrative staff, as this chart demonstrates.
Market capitalization per employee (in thousands of dollars) in the market segment - Holding
Streamex Corp (formerly BioSig Technologies) develops a system for reducing noise and artifacts in electrocardiograms, which is critical for cardiology. In the medical equipment industry, this metric reflects the market valuation of its unique technology. The chart shows the premium investors place on the company's ability to improve diagnostic accuracy.
Market capitalization per employee (in thousands of dollars) for the overall market
Streamex Corp., an associate of BioSig, is likely a holding company or technology company, possibly in the medical field. This chart will reflect the market valuation of its assets or intellectual property. A high cost per employee may indicate a model where value is concentrated in patents rather than operations.
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Streamex Corp (STEX)
Streamex (STEX) (via Biosig) is a company developing cutting-edge biosignal processing technologies, particularly for cardiology (PURE EP systems). This is medtech R&D. This chart shows the "cost" of developing this complex medical electronics—the negative profit (expense) per engineer.
Profit per employee (in thousands of dollars) in the market segment - Holding
Streamex Corp (STEX) (likely BioSig) – if it's BioSig, their business is developing the PURE EP system for obtaining clear cardiac signals during surgeries. Their business is medtech. This chart shows an industry benchmark that helps evaluate how (in)effectively the team is monetizing this technology. (This description is hypothetical.)
Profit per employee (in thousands of dollars) for the market as a whole
Standard Exploration (STEX) is a junior exploration company focused on mineral exploration. It is a venture-backed company at a very early stage. The company has no production and is not profitable. This chart does not reflect profitability, but rather the amount of investment capital (R&D costs) "burned" per geologist and employee during the exploration and evaluation of deposits.
Sales to employees of the company, segment and market as a whole
Sales per company employee Streamex Corp (STEX)
Streamex Corp is a holding company with interests in various sectors. This chart reflects the overall performance of its assets. The revenue per employee indicator will depend on the nature of the subsidiaries—whether they are operating businesses or passive investments—and will demonstrate how effectively the corporate center manages its portfolio.
Sales per employee in the market segment - Holding
Streamex (STEX) (associated with BioSig) is a holding company likely focused on the development and commercialization of medical technologies, such as electrophysiology systems. This chart shows the revenue (from R&D or licensing) generated by each employee. It reflects the stage of R&D and progress toward commercialization.
Sales per employee for the market as a whole
Streamex Corp (STEX) / BioSig is developing a cutting-edge system (PURE EP) for signal processing during cardiac arrhythmia treatments. They are an R&D company in the commercialization stage. This graph (near zero) shows their first steps: how their team of engineers and salespeople are trying to implement their innovative medical system in hospitals.
Short shares by company, segment and market as a whole
Shares shorted by company Streamex Corp (STEX)
Streamex Corp (STEX) — (Note: Likely a junk or shell company). This chart shows bearish bets. Shorts against such micro-cap companies are driven by a lack of real business, high volatility, pump-and-dump risk, or opaque operations.
Shares shorted by market segment - Holding
Streamex (STEX) (Biosig) is developing an innovative system (PURE EP) for more accurate cardiac signal reading during arrhythmia treatments. This chart shows the odds against the MedTech sector. The rising odds against the industry reflect investor skepticism about the commercialization of this niche technology and competition from the giants.
Shares shorted by the overall market
Streamex Corp is a holding company with a complex history, formerly known as BioSig. Such structures, especially after changes in operations, often suffer from a lack of transparency. When market fears (shown in this chart) mount, investors flee complexity and uncertainty, putting enormous pressure on such opaque holding companies.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Streamex Corp (STEX)
Streamex (STEX) is a speculative holding. When this general fear indicator rises (<30), investors sell small, illiquid, and unprofitable companies. This STEX chart reflects general panic/euphoria rather than specific business indicators. A level above 70 may be triggered by rare positive news or rumors.
RSI 14 Market Segment - Holding
Streamex Corp (part of Biosig) is a technology company operating in the medical field, likely with assets in digital data transfer or cardiology. This chart shows the overall sentiment in the diversified holdings sector. It helps us understand whether STEX's performance is driven by its specific holdings or is a general "wave" in the sector.
RSI 14 for the overall market
Streamex (STEX) is a biotech company. Like everything in its sector, it's critically dependent on this chart. Market euphoria is an opportunity to easily raise hundreds of millions of dollars for research. Market panic is the risk of running out of money before its breakthrough technologies reach patients.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast STEX (Streamex Corp)
Streamex (formerly BioSig) is a company specializing in biosignal processing technologies. Its flagship product is the PURE EP system, which helps electrophysiologists obtain clearer cardiac signals during ablation procedures. This chart shows the speculative average price target from analysts based on the implementation of this system.
The difference between the consensus estimate and the actual stock price STEX (Streamex Corp)
BioSig (STEX) is a clinical-stage medtech company developing the PURE EP system. This advanced signal processing technology is expected to improve the precision of cardiac surgeries (for arrhythmia). This chart shows the difference between the consensus forecast and the price, reflecting analysts' confidence in this R&D platform.
Analyst consensus forecast for stock prices by market segment - Holding
BioSig (STEX/BGSX) is a medical device company developing an advanced ECG signal processing system (PURE EP). Its goal is to provide cardiologists with a cleaner picture of the heart during complex procedures. This chart shows analysts' overall expectations for the entire holdings (and medical equipment) sector. It reflects whether experts believe demand for high-precision equipment will grow.
Analysts' consensus forecast for the overall market share price
Biosig (STEX) is a "medtech" company "developing" "advanced" "EKG" "systems" (for "cardiology"). This is an "R&D project." This chart of overall market sentiment is important. Optimism = "the market" is "willing" to "fund" "R&D" and "believe" in "breakthrough" "medical" "devices." Pessimism = "risk aversion" from "unprofitable" "medtech companies."
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Streamex Corp
Streamex (STEX) (likely related to BioSig) appears to be a medical technology company, possibly related to biosignaling or cardiology. This chart is likely a speculative R&D bet. Its valuation reflects the market's faith in their technology, their progress in clinical trials, and their ability to secure FDA approval.
AKIMA Market Segment Index - Holding
Streamex Corp (STEX), according to biosig.com, is associated with BioSig Technologies, a company developing signal processing systems for electrophysiology (medical equipment). This chart shows the average index for the holding segment. It helps investors assess how the company's overall performance compares to the industry average.
The AKIM Index for the overall market
Streamex Corp (formerly BioSig) is a company undergoing transformation or restructuring (it previously produced cardiac medical devices). This chart, reflecting the market average, is a backdrop. It helps assess how this micro-cap stock, in a state of uncertainty, compares to the overall macroeconomic picture.